英國央行：對於其他月份，公佈時間將從星期四延後一天至星期五。

The Trump administration is preparing to impose tariffs of up to 100% on certain imported medicines, potentially as soon as Thursday, targeting companies that have not agreed to boost US manufacturing, according to people familiar with the matter. The move follows earlier threats to penalize branded drug imports and is based on a national security probe under Section 232 of the Trade Expansion Act. Firms including Pfizer, AstraZeneca and Novo Nordisk have reached agreements to invest in the US and cut prices in exchange for tariff relief, while countries with trade deals may face lower, capped duties.

FED'S BARR SAYS BEEN DISSENTING ON POLICY AFFECTING REGULATIONS